0001426581-12-000005.txt : 20120514 0001426581-12-000005.hdr.sgml : 20120514 20120514122802 ACCESSION NUMBER: 0001426581-12-000005 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120331 FILED AS OF DATE: 20120514 DATE AS OF CHANGE: 20120514 EFFECTIVENESS DATE: 20120514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EXPO CAPITAL MANAGEMENT LLC CENTRAL INDEX KEY: 0001426581 IRS NUMBER: 208008350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-12799 FILM NUMBER: 12837442 BUSINESS ADDRESS: STREET 1: 11111 SANTA MONICA BLVD STREET 2: SUITE 1470 CITY: LOS ANGELES STATE: CA ZIP: 90025 BUSINESS PHONE: 310 201 7911 MAIL ADDRESS: STREET 1: 11111 SANTA MONICA BLVD STREET 2: SUITE 1470 CITY: LOS ANGELES STATE: CA ZIP: 90025 FORMER COMPANY: FORMER CONFORMED NAME: EXPO CAPITAK MANAGEMENT LLC DATE OF NAME CHANGE: 20080208 13F-HR 1 expo.txt EXPO CAPITAL - FORM 13F - PE 03.31.12 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: March 31, 2012 Check here if Amendment |_|;Amendment Number:_____ This Amendment (Check only one.): |_| is a restatement. |_| adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Expo Capital Management, LLC Address: 11111 Santa Monica Blvd. Suite 1470 Los Angeles, CA 90025 13F File Number: 28-12799 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Andrew Bzura Title: Chief Operating Officer Phone: 310-201-7911 Signature, Place, and Date of Signing: /s/ Andrew Bzura Los Angeles, CA May 14, 2012 ----------------------------------- ---------------- ------------------ [Signature] [City, State] [Date] Report Type (Check only one.): |X| 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) |_| 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) |_| 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 Form 13F Information Table Entry Total: 25 Form 13F Information Table Value Total: $523,782 (thousands) List of Other Included Managers: None Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. NONE Expo Capital Management, LLC March 31, 2012 FORM 13F INFORMATION TABLE
TITLE OF VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER CLASS CUSIP (x$1000)PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE ------------------------------------------------------------------------------------------------------------------------------ ALERE INC COM 01449J105 $18,857 725,000 SH Sole 725,000 ALLERGAN INC COM 018490102 $19,086 200,000 SH Sole 200,000 BROOKDALE SENIOR LIVING INC COM 112463104 $21,528 1,150,000 SH Sole 1,150,000 CENTENE CORP DEL COM 15135B101 $24,485 500,000 SH Sole 500,000 CEPHEID INC COM 15670R107 $21,961 525,000 SH Sole 525,000 CUBIST PHARMACEUTICALS INC COM 229678107 $20,544 475,000 SH Sole 475,000 ENDO PHARMACEUTICALS INC COM 29264F205 $27,111 700,000 SH Sole 700,000 GEN PROBE INC COM 36866T103 $18,263 275,000 SH Sole 275,000 HOLOGIC INC COM 436440101 $19,934 925,000 SH Sole 925,000 MEDICIS PHARMACEUTICAL CORP COM 584690309 $36,086 960,000 SH Sole 960,000 MOLINA HEALTHCARE INC COM 60855R100 $19,337 575,000 SH Sole 575,000 ONYX PHARMACEUTICALS INC COM 683399109 $20,724 550,000 SH Sole 550,000 PERKINELMER INC COM 714046109 $17,979 650,000 SH Sole 650,000 PSS WORLD MEDICAL INC COM 69366A100 $17,738 700,000 SH Sole 700,000 QIAGEN NV EUR COM N72482107 $21,020 1,350,000 SH Sole 1,350,000 SALIX PHARMACEUTICALS LTD COM 795435106 $18,375 350,000 SH Sole 350,000 SIRONA DENTAL SYSTEMS INC COM 82966C103 $23,193 450,000 SH Sole 450,000 THORATEC CORP COM 885175307 $19,383 575,000 SH Sole 575,000 UNITED THERAPEUTICS CORP COM 91307C102 $17,674 375,000 SH Sole 375,000 VCA ANTECH INC COM 918194101 $18,568 800,000 SH Sole 800,000 VOLCANO CORP COM 928645100 $26,252 925,000 SH Sole 925,000 WARNER CHILCOTT PLC COM G94368100 $18,491 1,100,000 SH Sole 1,100,000 WATERS CORP COM 941848103 $15,752 170,000 SH Sole 170,000 WATSON PHARMACEUTICALS INC COM 942683103 $23,471 350,000 SH Sole 350,000 WELLCARE HEALTH PLANS INC COM 94946T106 $17,970 250,000 SH Sole 250,000